€14.00
Your prediction
Financial data and news for OTC
sharewise wants to provide you with the best news and tools for OTC, so we directly link to the best financial data sources.
Financials
News
Arcturus Therapeutics Highlights mRNA Pipeline, CF Data and Vaccine Expansion at Jefferies
Key Points
- Interested in Arcturus Therapeutics Holdings Inc.? Here are five stocks we like better.
- Arcturus Therapeutics is expanding beyond vaccines and is now emphasizing therapeutic mRNA
Gemini Space Station Q1 Earnings Call Highlights
Gemini Space Station (NASDAQ:GEMI) reported higher first-quarter revenue as the crypto platform said it is moving to diversify beyond digital asset trading through credit cards, over-the-counter
Prestige Consumer Healthcare Q4 Earnings Call Highlights
Prestige Consumer Healthcare (NYSE:PBH) reported a weaker-than-expected fourth quarter as supply constraints in eye care and shipping disruptions tied to conflict in the Middle East weighed on
Ironwood Pharmaceuticals Q1 Earnings Call Highlights
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported a strong start to 2026 and reiterated its full-year outlook, pointing to sharp first-quarter
This 4/20, Wall Street Is Betting on More Than Marijuana
While many investors focused on the annual 4/20 holiday, expecting the usual buzz around marijuana stocks, a quiet revolution was unfolding in Washington. Over a weekend when most of the market was
3 Rare Earth Stocks Quietly Building the Next Supply Chain
Renewed geopolitical tensions and the global race for critical minerals are bringing rare earth stocks back into focus. In a recent conversation with Dylan Jovine of Behind the Markets
The Copper Shortage Is Coming—These 3 Miners Are Ready
Fear sells. But seeing a headline about a copper shortage should excite investors, not scare them. Particularly, investors who have a long-term outlook for basic materials stocks, including mining
3 Rare Earth Stocks to Watch Following Washington’s Latest Trade Moves
Trade-related news from Washington, including the push for Greenland, is sending ripples of volatility through rare-earth mining stocks. However, these stocks are well-positioned in 2026, as they
3 Innovative Crypto ETFs That May Surprise in 2026
After Bitcoin's tremendous rally to new highs around $126,000 last year, it shed essentially all of those gains in the final months of 2025 and is now down about 4% on a trailing-12-month basis
Better Cannabis Growth Stock: Trulieve or Vireo Growth
Investing in the cannabis sector means navigating a fast-moving landscape of corporate restructurings, consolidations, and massive regulatory shifts. Trulieve Cannabis (NYSE: TRLV) and Vireo Growth
Dow Jones Drops 1.4% as Trump Declares Iran Deal "Over"
Remember when the biggest market worry was whether Samsung's (OTC: SSNLF) earnings were too good? That was Tuesday, aka ages ago. By Wednesday, investors have moved on to weightier concerns such as
Samsung's Preliminary Quarterly Profit Just Jumped 19-Fold -- and Micron Stock Fell on the News. Here's Why.
Samsung Electronics (OTC: SSNLF) just issued preliminary results pointing to the most profitable quarter in its history. The South Korean electronics giant said Tuesday that it expects
The Nasdaq's Rough Day: When Good News Is Bad News for Market Indexes
Wall Street has a funny way of interpreting good news sometimes. Samsung Electronics (OTC: SSNLF) posted earnings that would make most companies weep with joy, and investors responded by hitting the
Is Green Thumb Stock Oversold? The Case for 100% Upside.
Green Thumb Industries (OTC: GTBIF) has only pulled back slightly in the months following last April's short-lived run-up among marijuana stocks. Yet while the shares have held fairly well, don't
Down 72% From Its Highs, Is Former Market Darling Adyen Stock Finally a Buy?
Although the broader market has soared amid the artificial intelligence (AI) boom, many stocks that were huge winners during the COVID-19 pandemic are still faltering. There may be no better example
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Summit Therapeutics (NASDAQ:SMMT) requires weighing the broad potential of artificial intelligence against the specific clinical
3 Reasons to Buy Green Thumb Industries Stock Hand Over Fist
Green Thumb Industries (OTC: GTBIF) has become one of the strongest operators in the U.S. cannabis industry. While many of its competitors continue to struggle with profitability, high debt, and
I Didn't Buy the SpaceX IPO. Here's Why, and What I Bought Instead.
Space Exploration Technologies' (NASDAQ: SPCX) initial public offering was a big hit. The company's share price is up 15% since market close on the day of its public debut even after a recent
2 Reasons This Is a Once-in-a-Decade Industrial Stock Pick for Long-Term Investors
The Iran conflict may finally be on its way to ending, but that does not change the future of defense and industrial spending in the United States. Modern conflicts -- from Ukraine to Venezuela to
The First U.S. Marijuana Stock Is Now Trading on the NYSE. Here's What That Means for Every Cannabis Investor.
Last week, Trulieve Cannabis (OTC: TCNNF) (NYSE:TRLV) became the first U.S. cannabis operator to list on the New York Stock Exchange. The stock is now trading under the symbol "TRLV."
Although a
Better Marijuana Stock to Buy Right Now: Tilray or Trulieve?
Trulieve (OTC: TCNNF) last week saidthat it had received approval to list on the New York Stock Exchange (NYSE), making it the first U.S. cannabis company to be listed on a major exchange. It began
1 Underappreciated Energy Stock You Won't Want to Overlook
Combining the listings on the Nasdaq stock exchange, the New York Stock Exchange (NYSE), and the over-the-counter (OTC) markets, over 12,000 stocks are trading in the U.S. That number is certainly
This AI Storage Stock is Up 560% so Far This Year. Is it Too Late to Buy? (Hint: It's Not Sandisk)
Many memory chip stocks skyrocketed over the past year as the AI market's demand for more memory chips for data centers outstripped the global supply. One of those top stocks was Sandisk (NASDAQ:
3 Reasons to Buy Green Thumb Industries Like There's No Tomorrow
The rescheduling of cannabis from a Schedule I to a Schedule III drug by the U.S. Department of Justice on April 23 means that the sector's stocks will no longer move in tandem with political winds
These Are Two of the Hottest Japanese Stocks. Should You Consider a $1,000 Investment?
The Japanese stock market is on fire. That market, as measured by the Nikkei 225 index (the equivalent of the S&P 500), is far outperforming the U.S. market this year. The Nikkei 225 has soared 35%


